<p>It is a significant challenge in image recognition, especially in medical imaging, where the diagnosis is still accurate and timely. Despite tremendous improvements, the ability to effectively identify and categorize pathological images like those used for cancer screening exhibits shortcomings in accuracy and efficiency. The need for enhanced diagnostic precision in early cancer identification has prompted the emergence of a novel Deep Learning (DL) framework known as “DeepScanAI.” The framework utilizes the potential of contour integrals and Convolutional Neural Networks (CNNs) to boost the effectiveness of cancer diagnosis in medical imaging. This preprocessing stage includes denoising, Contrast-Limited Adaptive (CLA), and contour-integral–based edge detection, which enhance hidden image features that highlight early-stage cancer patterns. DeepScanAI also has a specific training approach, which includes an enormous data set of tagged medical images covering different types and levels of cancer. To substantiate the scope and applicability of DeepScanAI in diagnostics, it is rigorously trained and tested on a diversified dataset composed of diverse cancer types like Breast, Lung, Colorectal, Gastroesophageal, and Brain cancer. This inclusivity ensures inclusive cancer detection across the entire range of oncological situations. Moreover, such diversity in training data guarantees that the model is accurate and generalizes well to unseen images. The result attainment of the model shows the unparalleled 96.3% detection rate for early-stage cancers, far better than standard methods hovering around 8%. DeepScanAI delivers its high accuracy level and saves time required for diagnostics, among essential factors influencing the prognosis. This approach can be considered a breakthrough in medical imaging that could significantly improve early cancer detection, resulting in better patient outcomes and survival.</p>